Cargando…
Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions
Primary mediastinal B‐cell lymphoma (PMBCL) is a distinct disease closely related to classical nodular sclerosing Hodgkin lymphoma. Conventional diagnostic paradigms utilising clinical, morphological and immunophenotypical features can be challenging due to overlapping features with other B‐cell lym...
Autores principales: | Lees, Charlotte, Keane, Colm, Gandhi, Maher K., Gunawardana, Jay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594147/ https://www.ncbi.nlm.nih.gov/pubmed/30740662 http://dx.doi.org/10.1111/bjh.15778 |
Ejemplares similares
-
Expanding the bacterial origins of nodular lymphocyte-predominant Hodgkin lymphoma
por: Gandhi, Maher K., et al.
Publicado: (2023) -
Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions
por: Chen, Huan, et al.
Publicado: (2021) -
CD4 T cells: the complicated key to unlocking the immune environment of classical Hodgkin lymphoma
por: Gandhi, Maher K., et al.
Publicado: (2022) -
The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma
por: Keane, Colm, et al.
Publicado: (2019) -
Current and emerging treatment options in primary mediastinal B-cell
lymphoma
por: Fakhri, Bita, et al.
Publicado: (2021)